Restricted accessArticle commentaryFirst published online 2012-02
History of the Clinical Endocrinology Branch of the National Institute of Diabetes and Digestive and Kidney Diseases: Impact on Understanding and Treatment of Diseases of the Thyroid Gland
RallJE. 1956. The role of radioactive iodine in the diagnosis of thyroid disease. Am J Med, 20:719–731.
2.
RobbinsJ, RallJE. 1960. Proteins associated with the thyroid hormones. Physiol Rev, 40:415–489.
3.
WolffJ. 1964. Transport of iodide and other anions in the thyroid gland. Physiol Rev, 44:45–90.
4.
GershengornMC, IzumiM, RobbinsJ. 1976. Use of lithium as an adjunct to radioiodine therapy of thyroid carcinoma. J Clin Endocrinol Metab, 42:105–111.
5.
EdelhochH. 1965. The structure of thyroglobulin and its role in iodination. Recent Prog Horm Res, 1:1–31.
6.
GavaretJM, CahnmannHJ, NunezJ. 1981. Thyroid hormone synthesis in thyroglobulin. The mechanism of the coupling reaction. J Biol Chem, 256:9167–9173.
7.
RobbinsJ, ChengSY, GershengornMC, GlinoerD, CahnmannHJ, EdelnochH. 1978. Thyroxine transport proteins of plasma. Molecular properties and biosynthesis. Recent Prog Horm Res, 34:477–519.
8.
RobbinsJ, DunnJT, BouvilleA, KravchenkoVI, LubinJ, PetrenkoS, SullivanKM, VanmiddlesworthL, WolffJ. 2001. Iodine nutrition and the risk from radioactive iodine: a workshop report in the Chernobyl long-term follow-up study. Thyroid, 11:487–491.
9.
NikodemVM, ChengSY, RallJE. 1980. Affinity labeling of rat liver thyroid hormone nuclear receptor. Proc Natl Acad Sci USA, 77:7064–7068.
10.
SwaroopA, KimD, ForrestD. 2010. Transcriptional regulation of photoreceptor development and homeostasis in the mammalian retina. Nat Rev Neurosci, 11:563–576.
GershengornMC, WeintraubBD. 1975. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone. A new syndrome of “inappropriate secretion of TSH”J Clin Invest, 56:633–642.
GershengornMC. 1986. Mechanism of thyrotropin releasing hormone stimulation of pituitary hormone secretion. Annu Rev Physiol, 48:515–526.
15.
SunY, ZupanB, RaakaBM, TothM, GershengornMC. 2009. TRH-receptor-type-2-deficient mice are euthyroid and exhibit increased depression and reduced anxiety phenotypes. Neuropsychopharmacology, 34:1601–1608.
16.
NeumannS, HuangW, TitusS, KrauseG, KleinauG, AlberobelloAT, ZhengW, SouthallN, IngleseJ, AustinCP, CeliFS, GavrilovaO, ThomasCJ, RaakaBM, GershengornMC. 2009. Small molecule agonists for the thyrotropin receptor stimulate thyroid function in human thyrocytes and mice. Proc Natl Acad Sci USA, 106:12471–12476.
17.
EngelS, SkoumbourdisAP, ChildressJ, NeumannS, DeschampsJR, ThomasCJ, ColsonAO, CostanziS, GershengornMC. 2008. A virtual screen for diverse ligands: discovery of selective G protein-coupled receptor antagonists. J Am Chem Soc, 130:5115–5123.
18.
NeumannS, RaakaBM, GershengornMC. 2009. Human TSH receptor ligands as pharmacological probes with potential clinical application. Expert Rev Endocrinol Metab, 4:669
